Post-mastectomy intensity modulated proton therapy after immediate breast reconstruction: Initial report of reconstruction outcomes and predictors of complications

The management of breast cancer requires multi-disciplinary collaboration in order to optimize oncologic outcomes and quality of life. Administration of post-mastectomy radiotherapy (PMRT) is indicated for some patients treated with mastectomy with clinical and pathologic risk factors associated with recurrence [1 –4]. Recently, the rates of mastectomy and contralateral prophylactic mastectomy for breast cancer have been on the rise for both early stage and locally advanced breast cancer [5–8]. This trend has been accompanied by an increase in immediate breast reconstruction (IBR), which has a number of p sychosocial advantages for patients [9,10].

Source: Radiotherapy and Oncology - June 7, 2019 Category: Radiology Authors: Na L. Smith, Krishan R. Jethwa, Jason K. Viehman, William S. Harmsen, Karthik Gonuguntla, Sarah M. Elswick, Jennifer N. Grauberger, Adam C. Amundson, Thomas J. Whitaker, Nicholas B. Remmes, Christin A. Harless, Judy C. Boughey, Minh-Doan T. Nguyen, Sean S Tags: Original Article Source Type: research